Lawyers and Settlements
Home Page >> Potential Lawsuit >> Drospirenone


Were you looking for Yasmin, Yaz, Ocella, Sayfral and Beyaz lawsuits?

The combination of contraceptive drugs Drospirenone and ethinyl estradiol has been associated with a number of Drospirenone side effects. Bayer, the manufacturer of oral contraceptives containing the Drospirenone drug is now facing thousands of Drospirenone lawsuits.



Send your Drospirenone claim to a lawyer who will review your claim at NO COST or obligation.Get Legal Help Now


yasminbirthcontrolyazpill3 Drospirenone, in combination with ethinyl estradiol, is used as an oral contraceptive in brand names such as Yasmin, Yaz and Safyral, (all made by Bayer) and Ocella, the generic brand of Yasmin (marketed and distributed by Barr Laboratories). These birth control pills, known as “4th generation” contraceptive pills, have also been used to treat the symptoms of menopause, moderate acne and osteoporosis.

Oral contraceptives such as Yasmin and Yaz, Safyral and Ocella contain the synthetic progesterone called drospirenone, which other and traditional oral contraceptives do not contain. The following contraceptives contain drospirenone:
  • Yaz
  • Yasmin
  • Ocella
  • Safyral
  • Syeda
  • Zarah
  • Beyaz
  • Gianvi
  • Loryna
See the FDA website for more information on FDA-approved oral birth control pills with drospirenone. Drospirenone acts as a female hormone that helps regulate ovulation and menstruation, while estradiol is a female hormone involved in development and maintenance of the female reproductive system.

Drospirenone Side Effects

Drospirenone and Heart Attack. Drospirenone (similar to other medicines typically used as diuretics such as Spironolactone), combined with ethinyl estradiol, has shown an increase in the blood’s potassium levels. This increase can lead to hyperkalemia, which can result in cardiac arrest. Hyperkalemia often has no symptoms, and is often detected after serious heart conditions have already occurred.

Drospirenone and Venous Thromboembolism (VTE). Drospirenone has also been associated with venous thromboembolism (VTE)—blood clots that form within a vein. A number of studies, most recently published in the BMJ (October 2011), suggest that women on these pills (listed above) containing one of the newer types of progestogen hormone (drospirenone, desogestrel or gestodene) have double the risk of VTE than women on pills containing an older progestogen (levonorgestrel). yasminbirthcontrolpillazsideeffects

Drospirenone and Deep Vein Thrombosis (DVT). Drospirenone has also been linked to deep vein thrombosis (DVT), which is a blood clot that forms in a deep vein, and pulmonary embolism—blood clots in the lungs. New research published in the Canadian Medical Association Journal (November, 2011) involving about 330,000 women in Israel found that women taking birth-control pills containing the drospirenone were as much as 65 per cent more likely to develop venous thromboembolism than women taking older generations of the pill.

Drospirenone and Gallbladder disease. It is also associated with gallbladder disease, particularly in young women.

As early as November 2009 the FDA had reports of 993 cases of pulmonary embolism (PE), 487 cases of DVT and 229 cases of other blood clots for Drospirenone and ethinyl estradiol combined.

The FDA and Drospirenone

The FDA released a safety announcement (September 2011) indicating a 1.5-fold increase in the risk of blood clots for women who use drospirenone-containing birth control pills compared to users of other hormonal contraceptives. In December 2011, an FDA advisory panel voted overwhelmingly to strengthen the warnings on drospirenone-containing birth control, to warn patients about the risk of blood clots associated with the contraceptives. The panel voted to keep the birth control on the market, although that vote was close, at 15 to 11.

The agency announced that a final report of its study that evaluated the risk of blood clots in users of several different hormonal contraceptives will be presented and discussed at the joint meeting of the Reproductive Health Drugs Advisory Committee on December 8, 2011.

In November 2011, Health Canada announced that its review found 1.5 to 3.0 times the risk of blood clots in women who used contraceptives that contain drospirenone. The health agency said that labels have been updated to include the warning and recommended that health care professionals consider the risks and benefits of birth control products that contain drospirenone when determining which contraceptives to prescribe.

Drospirenone Lawsuits

Bayer reported in mid-October 2009 that only 129 Yaz and Yasmin lawsuits had been filed in the US. As of February 2010, about 1,100 lawsuits had been filed in the US against Bayer, which said its product was no riskier than any other oral contraceptive on the market.

According to the Canadian Broadcasting Corp (CBC), by January 2011 more than 4,000 women in the US have taken legal action against Bayer and more than 800 women have joined a class action lawsuit in Canada.

Drospirenone lawsuits against Bayer—both involving side effects and deceptive marketing of Yaz and Yasmin--allege that the drug company:
  • Underplayed the risks associated with the products and overstated their approved uses in an effort to mislead users of Yaz and Yasmin into believing that the drugs were safe.
  • Failed to properly research the medication.
  • Failed to recall the drug after post-marketing reports demonstrated that the risk of potentially life-threatening side effects of Yasmin and Yaz outweighed potential benefits that could be achieved via other available oral contraceptives.

Drospirenone Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on


Implanon Reviews Could Steer Women Away From the Birth Control Device
Implanon Reviews Could Steer Women Away From the Birth Control Device Santa Cruz, CA:Women seeking a long-term birth control solution have probably heard about the implantable birth control device Implanon. However, if they somehow missed the news of Implanon lawsuits and rely on reviews at online health forums, what they find may steer those women away from using Implanon [READ MORE]

Young Mother Recounts Horrid Experience with Birth Control Implant
Young Mother Recounts Horrid Experience with Birth Control Implant Kenilworth, NJ: Her name is Lexi and she’s a young mother with a five-month-old baby who recounts in a YouTube video what turned out to be a horrid experience with Nexplanon birth control. Nexplanon, an implantable birth control device, is essentially the same product as Implanon birth control, only with the addition of barium sulfate to aid in locating the device for removal once the birth control device is depleted, usually after the third year [READ MORE]

Problems with Implantable Birth Control Removal Known Since 1994
Problems with Implantable Birth Control Removal Known Since 1994 Washington, DC: It’s been 10 years since Implanon birth control, the implantable device that lasts up to four years (three years on-label), was given formal approval by the US Food and Drug Administration (FDA). Twelve years before that, a research paper described the difficulty in extracting the six capsules inherent to a Norplant implantable birth control system. Over the intervening time from 1994 to the present day, a period of 23 years, concern has been raised over such implantable devices, the difficulty involved in device removal and the potential for device migration [READ MORE]


Posted by
Janet storing
My 17 year old daugher just suffered a pulmonary embolism. She was prescribed this pill in 2015 for help in regulation of her cycle and for acne. Our peds doc never at anytime said anything about this risk. The package that contains this product has no warnings. We feel our medical bills should be covered as well as compensation to our daughter. Her life this past week changed forever and we feel they are negligent.


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Drospirenone Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Subscribe to our free weekly newsletter.

Check Claim Status Advertise with us Legal Funding

Related Lawsuits

Legal Services:


FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.

Visit other Online Legal Media Websites:
Get Legal Help